Ticker: STT

State Street Corporation

Finance Financials Asset Management

Price 185.40

Reco Buy Potential 74 Risk 32 Updated 2026-07-27

Official website

Forecast impact

limited

Target +7.9% target fill 92.7%

Reaction D5 pending · D10 pending fresh confirmed · market trust

Impact Potential 0 · Risk 0 valid until 2026-08-19

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

State Street Corporation is a financial services company that provides investment management, servicing, and administration solutions. Its core products include asset management, investment research, and trading services. Major business segments encompass Investment Management and Investment Servicing, with primary revenue sources derived from management fees, servicing fees, and performance fees. The company serves institutional investors, including pension funds, endowments, and foundations.

Investment Profile

The investment profile of State Street Corporation is more aligned with dividends and value investors, given its consistent dividend yield and established market presence. The stock may appeal to those seeking income through dividends while also considering potential capital appreciation. Its moderate volatility suggests a balanced risk approach.

Category: Finance Sector: Financials Industry: Asset Management Investment style: Balanced Horizon: Medium-term Company type: Blue Chip Company type: Large Cap Experience: Basic

Fundamental metrics (experimental) Updated: 2026-07-27

EPS (TTM) — earnings per share for the last 12 months, $: 10.01
Revenue QoQ — quarter-over-quarter revenue growth: 0.3%
EPS surprise: 4.6%
20d volatility: 1.3%
Dividend yield: 3.3%
last ex-date: 2026-04-01

AI recommendation changes

Date	Before	After	Reason
2026-05-28	Hold	Buy	Strong momentum, but revenue decline raises concerns.
2026-05-20	Buy	Hold	Mixed performance; caution advised due to revenue decline.
2026-05-16	Hold	Buy	Solid fundamentals, but revenue decline raises concerns.
2026-05-08	—	Hold	Mixed performance; cautious due to revenue decline.
2026-05-08	Buy	Hold	Компания демонстрирует стабильный рост за последние 120 дней, однако недавнее снижение выручки и волатильность цен могут указывать на определенные риски. Дивидендная доходность также привлекательна, что делает акцию инте
2026-04-09	Hold	Buy	Компания показывает положительную динамику на рынке с ростом цен за последние 20 и 120 дней. Высокая дивидендная доходность и умеренный риск делают её привлекательной для инвестиций.
2026-03-07	Buy	Hold	Компания демонстрирует стабильный рост за последние 120 дней, однако недавние падения цен и значительное снижение выручки в квартальном исчислении вызывают опасения. Дивидендная доходность остается привлекательной, что м
2026-03-05	Hold	Buy	Компания демонстрирует стабильный рост за последние 120 дней, однако недавнее снижение выручки и волатильность на коротких временных интервалах указывают на необходимость осторожности.
2026-02-24	Buy	Hold	Компания демонстрирует стабильный рост на длительных горизонтах, однако недавнее снижение выручки вызывает опасения. Дивидендная доходность также привлекательна, что делает акцию интересной для удержания.
2026-02-14	Hold	Buy	Компания демонстрирует стабильный рост за последние 60 и 120 дней, однако недавнее снижение выручки и волатильность цен могут указывать на риски. Рекомендуется удерживать акции до более ясной картины.
2026-02-06	Buy	Hold	Компания показывает стабильный рост за последние 60 и 120 дней, однако недавние колебания цен указывают на возможные краткосрочные риски. Рекомендуется удерживать акции до более ясной картины рынка.
2026-01-27	Hold	Buy	Компания показывает положительную динамику на длительном горизонте, особенно за последние 120 дней, что указывает на устойчивый рост. Тем не менее, краткосрочные колебания требуют осторожности, но в целом перспективы выг

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-07-20	Evercore ISI	Target Raised	186 → 200	183.985
2026-07-17	Truist Financial	Target Raised	176 → 191	183.215
2026-07-17	Morgan Stanley	Target Raised	183 → 195	185.66
2026-07-17	Barclays	Target Raised	165 → 200	185.66
2026-07-06	Evercore ISI	Target Raised	158 → 186	174.415
2026-06-30	Goldman Sachs	Target Raised	168 → 194	170.18
2026-06-29	Morgan Stanley	Target Raised	166 → 183	170.535
2026-06-26	UBS	Target Raised	150 → 176	166.65
2026-05-26	Wells Fargo	Target Raised	162 → 171	153.95
2026-04-21	Argus Research	Target Raised	140 → 168	155.56
2026-04-20	Seaport Global	Target Raised	154 → 170	149.28
2026-04-20	Truist Financial	Target Raised	136 → 150	148.735
2026-04-20	Morgan Stanley	Target Raised	155 → 166	149.225
2026-04-20	Evercore ISI	Target Raised	140 → 158	149.21
2026-04-20	RBC Capital	Target Raised	135 → 155	148.82
2026-04-20	Goldman Sachs	Target Raised	152 → 168	145.43
2026-04-20	Barclays	Target Raised	152 → 165	145.43
2026-01-20	Truist Financial	Target Lowered	138 → 136	124.7

News Page 1 of 1

Biotech Sector Remains Attractive to Investors Following Significant Recovery

07/22/2026, 01:37 PM investing review biotech healthcare Franklin Templeton (BEN) State Street Corporation Revolution Medicines

Investors in the biotechnology sector are maintaining a positive outlook following significant gains this year, driven by factors such as potential mergers and acquisitions and a recovery in clinical trials. The performance of key ETFs and specific companies, like Revolution Medicines, highlights the sector's resilience and growth potential.

DTCC Completes Tokenization Trial with Major Financial Firms Including JPMorgan and Goldman Sachs

07/15/2026, 08:36 AM economy announcement finance JPMorgan Chase Goldman Sachs SPDR S&P 500 ETF Trust Microsoft BlackRock State Street Corporation Invesco Vanguard

The Depository Trust and Clearing Corporation (DTCC) is conducting a significant trial of tokenized assets, involving major financial firms, which could pave the way for broader adoption of blockchain technology in traditional finance.

Analysts Gavekal recommend buying Japanese government bonds as yields reach multi-decade highs

07/13/2026, 04:36 PM recommendation Analysts: analysts finance State Street Corporation

Japanese government bond yields have surged to multi-decade highs, prompting analysts to suggest that these bonds may now be an attractive investment option for global investors, despite some concerns about Japan's fiscal sustainability.

Analysts Ritholtz Wealth Management highlight Merck (MRK), Archer-Daniels-Midland (ADM), and State Street (STT) as strong stocks in underperforming sectors

07/06/2026, 08:37 AM investing review Analysts: analysts, Ritholtz healthcare consumer Archer-Daniels-Midland State Street Corporation Merck

Investors are encouraged to consider stocks in underperforming sectors, as recent analysis highlights potential opportunities in companies like Merck, Archer-Daniels-Midland, and State Street, which are showing strength despite broader market challenges.

U.S. Treasury Announces Investment Options for Trump Accounts Including ETFs from State Street, BlackRock, and Vanguard

07/02/2026, 08:36 AM business announcement BlackRock State Street Corporation Vanguard

The U.S. Treasury has announced that Trump Accounts will invest in ETFs from major firms like State Street, BlackRock, and Vanguard, providing a new investment avenue for families with children under 18. This initiative is significant as it encourages early investment in the stock market for future generations.

Analysts recommend selling July $56 put on State Street Energy Select Sector SPDR ETF (XLE) to capitalize on oil price volatility

06/10/2026, 08:32 AM investing recommendation Analysts: analysts energy Energy Select Sector SPDR Fund State Street Corporation

Energy equities are experiencing a pullback, but ongoing geopolitical tensions and supply disruptions suggest that oil prices may remain supported. Investors can capitalize on this volatility by selling puts on the State Street Energy Select Sector SPDR ETF (XLE) to potentially acquire shares at a discount.